epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aptiom
    eslicarbazepine acetate
  • remove Lamictal ODT
    lamotrigine

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Aptiom (eslicarbazepine acetate) + Lamictal ODT (lamotrigine)

Caution Advised


eslicarbazepine acetate + lamotrigine

caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Additional Considerations

Smiley face Smiley face lamotrigine in Lamictal ODT

caution advised with other sodium channel blockers; combo may increase risk of ECG changes, cardiac arrhythmias; additive effects

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information